The effect of long-term treatment with erythromycin on Th1 and Th2 cytokines in diffuse panbronchiolitis

Biochemical and Biophysical Research Communications

Volumn 324, Issue 1, 2004, Pages 114-117

  Park, Seoung Ju ^a   Lee, Yong Chul ^a   Rhee, Yang Keun ^a   Lee, Heung Bum ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Cytokine; Diffuse panbronchiolitis; Erythromycin; T cell

Indexed keywords

ERYTHROMYCIN; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

ADULT; AGED; ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DRUG EFFECT; FEMALE; HUMAN; IMMUNOMODULATION; LUNG LAVAGE; LYMPHOCYTE; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; BRONCHIOLITIS; BRONCHOALVEOLAR LAVAGE FLUID; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; ERYTHROMYCIN; FEMALE; HUMANS; MALE; MIDDLE AGED; TH1 CELLS; TH2 CELLS; TIME FACTORS;

EID: 4744376119     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.09.018     Document Type: Article

References (22)

1. H. Homma, A. Yamanaka, S. Tanimoto, M. Tamura, Y. Chijimatsu, S. Kira, and T. Izumi Diffuse panbronchiolitis. A disease of the transitional zone of the lung Chest 84 1983 63 69
2. Y. Sugiyama Diffuse panbronchiolitis Clin. Chest Med. 14 1993 765 772
3. Y.W. Kim, S.K. Han, Y.S. Shim, K.Y. Kim, Y.C. Han, J.W. Seo, and J.G. Im The first report of diffuse panbronchiolitis in Korea: five case reports. Intern. Med. 31 1992 695 701
4. J.E. Fitzgerald, T.E. King Jr., D.A. Lynch, R.M. Tuder, and M.I. Schwarz Diffuse panbronchiolitis in the United States Am. J. Respir. Crit. Care Med. 154 1996 497 503
5. J.A. Martinez, S.M. Guimaraes, R.G. Ferreira, and C.A. Pereira Diffuse panbronchiolitis in Latin America Am. J. Med. Sci. 319 2000 183 185
6. K. Yanagihara, J. Kadoto, and S. Kohno Diffuse panbronchiolitis - pathophysiology and treatment mechanisms Int. J. Antimicrob. Agents 18 2001 S83 S87
7. H. Nagai, H. Shishido, R. Yoneda, E. Yamaguchi, A. Tamura, and A. Kurashima Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis Respiration 58 1991 145 149
8. J. Tredaniel, G. Zalcman, F. Gerber, M.F. D'Agay, F. Capron, J. Frija, and A. Hirsch Diffuse panbronchiolitis: efficacy of low-dose erythromycin Respir. Med. 87 1993 229 230
9. S. Kudoh, T. Uetake, K. Hagiwara, M. Hirayama, L.H. Hus, H. Kimura, and Y. Sugiyama Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis Nihon Kyobu Shikkan Gakkai Zasshi 25 1987 632 642
10. T. Fujii, J. Kadota, K. Kawakami, K. Iida, R. Shirai, M. Kaseda, S. Kawamoto, and S. Kohno Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection Thorax 50 1995 1246 1252
11. K. Matsumoto New approaches to Pseudomonas aeruginosa lower respiratory tract infections Verh. K. Acad. Geneeskd. Belg. 57 1995 109 122
12. H. Takizawa, M. Desaki, T. Ohtoshi, S. Kawasaki, T. Kohyama, M. Sato, M. Tanaka, T. Kasama, K. Kobayashi, J. Nakajima, and K. Ito Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells Am. J. Respir. Crit. Care Med. 156 1997 266 271
13. H. Mukae, J. Kadota, S. Kohno, S. Kusano, T. Morikawa, S. Matsukura, and K. Hara Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Am. J. Respir. Crit. Care Med. 152 1995 613 618
14. T. Mitsuyama, T. Tanaka, K. Hidaka, M. Abe, and N. Hara Inhibition by erythromycin of superoxide anion production by human polymorphonuclear leukocytes through the action of cyclic AMP-dependent protein kinase Respiration 62 1995 269 273
15. C. Wenisch, B. Parschalk, K. Zedtwitz-Liebenstein, A. Weihs, I. el Menyawi, and W. Graninger Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry Antimicrob. Agents Chemother. 40 1996 2039 2042
16. H. Abdelghaffar, E.M. Mtairag, and M.T. Labro Effects of dirithromycin and erythromycylamine on human neutrophil degranulation Antimicrob. Agents Chemother. 38 1994 1548 1554
17. H. Abdelghaffar, D. Vazifeh, and M.T. Labro Comparison of various macrolides on stimulation of human neutrophil degranulation in vitro J. Antimicrob. Chemother. 38 1996 81 93
18. O. Sakito, J. Kadota, S. Kohno, K. Abe, R. Shirai, and K. Hara Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy Respiration 63 1996 42 48
19. T. Ichiyama, M. Nishikawa, T. Yoshitomi, S. Hasegawa, T. Matsubara, T. Hayashi, and S. Furukawa Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells Antimicrob. Agents Chemother. 45 2001 44 47
20. J. Tamaoki The effects of macrolides on inflammatory cells Chest 125 2004 S41 S50
21. J. Kadota, Y. Matsubara, Y. Ishimatsu, M. Ashida, K. Abe, R. Shirai, K. Iida, K. Kawakami, H. Taniguchi, T. Fujii, M. Kaseda, S. Kawamoto, and S. Kohno Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB) Clin. Exp. Immunol. 103 1996 461 466
22. T.R. Mosmann, and S. Sad The expanding universe of T-cell subsets: Th1, Th2 and more Immunol. Today 17 1996 138 146